APHP Pitié-Sampetriere
Paris, 75013, France
NCT Number: NCT01704612
Diabete animal studies demonstrated a longer period recovery after local anesthetic injection (perineural administration). No clinical study demonstrated a prolonged nerve block duration in diabete type 2 patients after peripheral nerve block. The investigators hypothesized that block recovery is delayed in diabetic patients.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Interventional
Phase 4
Paris, 75013, France
For diabetic patients, peripheral nerve block is an interesting alternative to general anesthesia because it provides effective analgesia and may decrease haemodynamic complication. The fear of nerve injury after regional anaesthesia in diabetic patients is a concern that has neither been confirmed nor refuted by current literature. As a matter of fact, diabetic patients with neuropathy may be considered at increased risk because of the possibility for double crush syndrome when a chronic axon lesion related to diabetes is associated with an unexpected distal nerve injury related to regional anaesthesia.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients received 20 mL ropivacaine 5 mg/mL on subgluteal nerve
Other names: naropin
Time frame: Day 0
The beginning of this term is defined by the end of the sciatic block injection, and the end of this period is defined by the reappearance of sensitivity to pin-prick test
Time frame: Day 0
The beginning of this term is defined by the end of the sciatic block injection, and the end of this period is defined by the reappearance of motor function
Time frame: Day 0
peroperative period
Time frame: Day 0
perop
Time frame: 1 month
Pierre and Marie Curie University
Other
Comparison of Subgluteal Sciatic Nerve Block Duration in Type-2 Diabetic and Non Diabetic Patients
Acronym: Diabeteblock
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06319300
Diabetes Mellitus, Diabetes Mellitus, Type 2
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT02107976
Diabetes Mellitus, Diabetes Mellitus, Type 2
Bethesda, Maryland, United States
View Trial DetailsNCT05378620
Diabetes Mellitus, Diabetes Mellitus, Type 2
National City, California, United States
View Trial DetailsNCT05014204
Diabetes, Diabetes Mellitus
Los Angeles, California, United States
View Trial Details